(Q36714541)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Vaccine-based approaches to squamous cell carcinoma of the head and neck (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Zhang X

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Moche JA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Strome SE

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

17-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241425%20AND%20SRC:MED&resulttype=core&format=json

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

CD28-B7 interactions in T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

TAT-mediated protein transduction into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

TAP-independent presentation of CTL epitopes by Trojan antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

The potential of human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01329.X